ORACIP

This brand name is authorized in Nigeria.

Active ingredients

The drug ORACIP contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100818	Tablet	Oracip - 500 Tablet TAB 500 mg 1 x 10's (blister)	Tablet ORACIP - 500 TABLET CIPROFLOXACIN HCL BP 500MG, AVICEL PH 102/101 BP 90MG, CORN STARCH 90MG, SODIUM METHYL PARABEN BP 0.80MG, SODIUM PROPYL PARABEN BP 0.20MG, TALCUM BP 5MG, SODIUM STARCH GLYCOLATE BP 22MG, MAGNESIUM STEARATE BP 5MG, AEROSIL BP 4MG A11-100818 Drugs Nigerian Products 110 22-05-2024 GLOBAL ORGANICS LTD, PLOT NO 868, KM 34 AJEGUNLE BUS-STOP, LAGOS ABEOKUTA EXPRESSWAY, LAGOS STATE. 017747123 info@globorg.net GLOBAL ORGANICS LIMITED, PLOT NO 868, KM 34 AJEGUNLE BUS-STOP, LAGOS ABEOKUTA EXPRESSWAY, LAGOS STATE	27/03/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100818